Company Description
RELX PLC, together with its subsidiaries, provides information-based analytics and decision tools for professional and business customers in North America, Europe, and internationally.
It operates through four segments: Risk; Scientific, Technical & Medical; Legal; and Exhibitions. The Risk segment offers information-based analytics and decision tools that combine public and industry specific content with technology and algorithms to assist clients in evaluating and predicting risk.
The Scientific, Technical & Medical segment provides scientific and medical information and data sets that help researchers and healthcare professionals to advance science and health outcomes.
The Legal segment provides legal, regulatory, and business information and analytics that help customers in decision-making, as well as increases the productivity.
The Exhibitions segment is involved in the business that combines face-to-face with data and digital tools to help customers learn about markets, source products, and transactions.
The company was formerly known as Reed Elsevier PLC and changed its name to RELX PLC in July 2015. RELX PLC was incorporated in 1903 and is headquartered in London, the United Kingdom.
| Country | United Kingdom |
| Founded | 1903 |
| Industry | Specialty Business Services |
| Sector | Industrials |
| Employees | 36,500 |
| CEO | Erik Engstrom |
Contact Details
Address: 1-3 Strand London, WC2N 5JR United Kingdom | |
| Phone | 44 20 7166 5500 |
| Website | relx.com |
Stock Details
| Ticker Symbol | RELX |
| Exchange | NYSE |
| Fiscal Year | January - December |
| Reporting Currency | GBP |
| CIK Code | 0000929869 |
| CUSIP Number | 759530108 |
| ISIN Number | US7595301083 |
| SIC Code | 7389 |
Key Executives
| Name | Position |
|---|---|
| Michael Walsh | Chief Executive Officer of Legal |
| Mark Kelsey | Chief Executive Officer of Risk |
| Kumsal Bayazit Besson | Chief Executive Officer of Scientific, Technical and Medical |
| Erik Engstrom M.Sc Econ, M.Sc Eng., MBA | Chief Executive Officer and Executive Director |
| Nicholas Lawrence Luff | Chief Financial Officer and Executive Director |
| Colin Tennant | Head of Investor Relations |
| Henry Adam Udow IV, J.D. | Chief Legal Officer and Company Secretary |
| Paul Abrahams | Head of Corporate Communications |
| Rosemary Thomson | Chief Human Resources Officer |
| Dr. Márcia Balisciano | Global Head of Corporate Responsibility |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Mar 7, 2025 | 6-K | Report of foreign issuer |
| Mar 3, 2025 | 6-K | Report of foreign issuer |
| Feb 20, 2025 | 6-K | Report of foreign issuer |
| Feb 20, 2025 | 6-K | Report of foreign issuer |
| Feb 20, 2025 | 6-K | Report of foreign issuer |
| Feb 20, 2025 | IRANNOTICE | Notice of disclosure filed pursuant to Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 |
| Feb 20, 2025 | 20-F | Annual and transition report of foreign private issuers |
| Feb 19, 2025 | 6-K | Report of foreign issuer |
| Feb 18, 2025 | 144 | Filing |
| Feb 18, 2025 | 6-K | Report of foreign issuer |